Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 5/20 | 0.44 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11456405 | 0.88 | MAPT (0.52) | LMNAPOLBALDH1A1MEN1KMT2A | |
| SCHEMBL11518818 | 0.81 | LMNA (0.45) | LMNAPOLBTSHRALDH1A1MEN1 | |
| SCHEMBL11214694 | 0.81 | AKR1C3 (0.60) | LMNAALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL788438 | 0.81 | LMNA (0.52) | LMNAPOLBTSHRALDH1A1MEN1 | |
| SCHEMBL776346 | 0.81 | ALDH1A1 (0.54) | LMNAALDH1A1MEN1KMT2ACES1 | |
| SCHEMBL13231630 | 0.79 | ALDH1A1 (0.55) | LMNAPOLBTSHRALDH1A1CES1 | |
| SCHEMBL4851005 | 0.79 | HPGD (0.53) | LMNAPOLBTSHRALDH1A1CES1 | |
| SCHEMBL4610734 | 0.79 | CES2 (0.57) | LMNAALDH1A1MEN1KMT2ACES1 | |
| SCHEMBL11411158 | 0.79 | CA1 (0.55) | POLBTSHRALDH1A1MEN1KMT2A | |
| SCHEMBL27884622 | 0.79 | LMNA (0.50) | LMNAPOLBTSHRALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8642676-B2 | Polymerizable composition and acrylic resin film | MITSUBISHI RAYON CO., LTD. (JP) | 2014-02-04 | — | — | US | claimed |
| EP-3666247-B1 | DIVIDED CURABLE COMPOSITION | MITSUI CHEMICALS INC (JP) | 2024-12-18 | — | — | EP | disclosed |
| US-11844847-B2 | Sulfur-containing polymerizable monomer and use thereof | SUN MEDICAL CO., LTD. (JP) | 2023-12-19 | — | — | US | disclosed |
| CN-112513016-B | Sulfur-containing polymerizable monomer and use thereof | 尚美德齿科材料有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-11744782-B2 | Separately packed curable composition | MITSUI CHEMICALS, INC. (JP) | 2023-09-05 | — | — | US | disclosed |
| EP-3658065-B1 | MICRO-APPLICATOR FOR USE WITH DENTAL ADHESIVES | KULZER & CO GMBH (DE) | 2023-07-26 | — | — | EP | disclosed |
| CN-112940432-B | Polymerizable monomer for dental material, composition, adhesive dental material, and kit | 三井化学株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-115197448-A | Spherical powder comprising crosslinked material having polyrotaxane, and method for producing same | 株式会社ASM | 2022-10-18 | — | — | CN | disclosed |
| CN-109843986-B | Spherical powder comprising crosslinked material having polyrotaxane, and method for producing same | 株式会社ASM | 2022-08-16 | — | — | CN | disclosed |
| US-11306160-B2 | Curable composition | MITSUI CHEMICALS, INC. (JP) | 2022-04-19 | — | — | US | disclosed |
| US-6576725-B1 | Iron compound, organomagnesium compound, and alpha-acylphosphonate diester; addition polymerization | BRIDGESTONE CORPORATION (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20030073570-A1 | Method of preparing oligomers of conjugated dienes with an iron-based catalyst composition | BRIDGESTONE CORP. | 2003-04-17 | — | — | US | disclosed |
| US-20030073790-A1 | Iron-based catalyst composition for the manufacture of syndiotactic 1, 2-polybutadiene | BRIDGESTONE CORP. | 2003-04-17 | — | — | US | disclosed |
| WO-2003018644-A1 | IRON-BASED CATALYST COMPOSITION FOR THE MANUFACTURE OF SYNDIOTACTIC 1,2-POLYBUTADIENE | BRIDGESTONE CORPORATION (JP) | 2003-03-06 | — | — | WO | disclosed |
| US-6288138-B1 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| EP-0923924-A2 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
| EP-0473643-B1 | PHOTOCURABLE PIGMENTED SECONDARY OPTICAL FIBER COATINGS | DSM NV (NL) | 1994-12-14 | — | — | EP | disclosed |
| US-4472577-A | CATALYTIC HYDROGENATION OF ALPHA-OXO-PHOSPHONIC ACID ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1984-09-18 | — | — | US | disclosed |
| EP-0071805-A2 | Process for the preparation of alpha-hydroxy-phosphonic-acid esters | BAYER AG (DE) | 1983-02-16 | — | — | EP | disclosed |
| EP-0042567-A2 | Photopolymerisable mixtures with aroylphosphonic acid esters as photoinitiators | BAYER AG (DE) | 1981-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306160-B2 | Curable composition | COIL, CLPX, CBX7 | LMNA 1573/4885POLB 1012/4885TSHR 4794/4885 |
| US-11844847-B2 | Sulfur-containing polymerizable monomer and use thereof | MGMT, SETDB1, ASH2L | LMNA 2881/4885POLB 568/4885TSHR 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.